Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 9.9B | 8.5B | 8.7B | 8.0B |
Cost of revenue | 5.1B | 4.1B | 4.1B | 3.8B |
Gross profit | 4.9B | 4.3B | 4.6B | 4.2B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 1.6B | 1.4B | 1.5B | 1.3B |
Operating income | 1.3B | 1.0B | 1.2B | 948.9M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 79.5M | 55.7M | 84.1M | 85.7M |
Other income expense | — | — | — | — |
Pretax income | 1.4B | 1.1B | 1.3B | 1.0B |
Tax provision | 382.4M | 300.4M | 359.6M | 271.6M |
Net income | 1.0B | 805.8M | 947.2M | 728.4M |
Basic EPS | — | 2.6 | 3.0 | 2.3 |
Diluted EPS | — | 2.6 | 3.0 | 2.3 |
Basic average shares | — | 316.4M | 316.4M | 316.2M |
Diluted average shares | — | 316.4M | 316.4M | 316.3M |
EBITDA | 1.7B | 1.3B | 1.6B | 1.3B |
Net income from continuing op. | — | — | — | — |
Minority interests | 0 | 0 | 0 | 0 |
Preferred stock dividends | 0 | 0 | 0 | 0 |